Low prevalence of post-COVID-19 syndrome in patients with asthma
| Errataetall: |
CommentOn: Anticancer Drug Des. 1987 Apr;1(4):323-35. - PMID 3450302 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:82 |
|---|---|
| Enthalten in: |
The Journal of infection - 82(2021), 6 vom: 30. Juni, Seite 276-316 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Garcia-Pachon, Eduardo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
9007-49-2 |
|---|
| Anmerkungen: |
Date Completed 19.05.2021 Date Revised 11.05.2022 published: Print-Electronic CommentOn: Anticancer Drug Des. 1987 Apr;1(4):323-35. - PMID 3450302 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jinf.2021.03.023 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM323749348 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM323749348 | ||
| 003 | DE-627 | ||
| 005 | 20231225184841.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jinf.2021.03.023 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1079.xml |
| 035 | |a (DE-627)NLM323749348 | ||
| 035 | |a (NLM)33819552 | ||
| 035 | |a (PII)S0163-4453(21)00156-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Garcia-Pachon, Eduardo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Low prevalence of post-COVID-19 syndrome in patients with asthma |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.05.2021 | ||
| 500 | |a Date Revised 11.05.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: Anticancer Drug Des. 1987 Apr;1(4):323-35. - PMID 3450302 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a Asthma | |
| 650 | 4 | |a Coronavirus | |
| 650 | 4 | |a Symptoms | |
| 650 | 7 | |a Carbazoles |2 NLM | |
| 650 | 7 | |a Intercalating Agents |2 NLM | |
| 650 | 7 | |a DNA |2 NLM | |
| 650 | 7 | |a 9007-49-2 |2 NLM | |
| 650 | 7 | |a ditercalinium |2 NLM | |
| 650 | 7 | |a VFS4ZUK33P |2 NLM | |
| 700 | 1 | |a Grau-Delgado, Justo |e verfasserin |4 aut | |
| 700 | 1 | |a Soler-Sempere, Maria J |e verfasserin |4 aut | |
| 700 | 1 | |a Zamora-Molina, Lucia |e verfasserin |4 aut | |
| 700 | 1 | |a Baeza-Martinez, Carlos |e verfasserin |4 aut | |
| 700 | 1 | |a Ruiz-Alcaraz, Sandra |e verfasserin |4 aut | |
| 700 | 1 | |a Padilla-Navas, Isabel |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 82(2021), 6 vom: 30. Juni, Seite 276-316 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
| 773 | 1 | 8 | |g volume:82 |g year:2021 |g number:6 |g day:30 |g month:06 |g pages:276-316 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2021.03.023 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 82 |j 2021 |e 6 |b 30 |c 06 |h 276-316 | ||